Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Agiliti (AGTI) Stock Forecast & Price Target

Agiliti logo
Get the Latest News and Ratings for AGTI and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Agiliti and its competitors.

Sign Up

AGTI Analyst Ratings Over Time

TypeCurrent Forecast
11/1/23 to 10/31/24
1 Month Ago
10/2/23 to 10/1/24
3 Months Ago
8/3/23 to 8/2/24
1 Year Ago
11/1/22 to 11/1/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
2 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$13.67$13.67$14.17$16.14
Forecasted Upside35.99% Upside35.99% Upside40.96% Upside189.82% Upside
Consensus Rating
Hold
Hold
Reduce
Hold

AGTI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

AGTI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Agiliti Stock vs. The Competition

TypeAgilitiMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.79
2.50
Consensus RatingHoldModerate BuyHold
Predicted Upside35.99% Upside16,138.55% Upside10.21% Upside
News Sentiment Rating
Neutral News

See Recent AGTI News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/26/2024Raymond James
4 of 5 stars
 Reiterated RatingMarket Perform ➝ Market Perform
3/7/2024UBS Group
4 of 5 stars
 Reiterated RatingBuy ➝ Neutral$10.00+0.86%
2/6/2024KeyCorp
3 of 5 stars
 Initiated CoverageSector Weight
1/4/2024Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$23.00+212.08%
11/14/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderweight ➝ Underweight$10.00 ➝ $8.00+16.96%
9/5/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underperform$18.00 ➝ $11.00+12.36%
8/15/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$20.00 ➝ $13.00+10.97%
11/14/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$23.00 ➝ $20.00+33.33%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 08:49 PM ET.


AGTI Forecast - Frequently Asked Questions

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Agiliti is $13.67, with a high forecast of $23.00 and a low forecast of $8.00.

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Agiliti in the last year. There is currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AGTI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AGTI, but not buy additional shares or sell existing shares.

According to analysts, Agiliti's stock has a predicted upside of 35.99% based on their 12-month stock forecasts.

Analysts like Agiliti less than other "medical" companies. The consensus rating for Agiliti is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how AGTI compares to other companies.


This page (NYSE:AGTI) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners